Full Text View
Tabular View
No Study Results Posted
Related Studies
Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections
This study has been terminated.
Study NCT00102947   Information provided by Cubist Pharmaceuticals
First Received: February 4, 2005   Last Updated: May 21, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Soft Tissue Infections
Additional conditions recognized in this trial
Communicable Diseases
Infection
Interventions listed in this trial
daptomycin (up to 14 days)
Additional drug interventions recognized in this trial
Daptomycin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Cubist Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services